Patient-Specific Formulations of Approved Molecules
A compounding pharmacy is a state-licensed, FDA-regulated pharmacy that can prepare custom formulations of medications for specific patients. This has existed for decades — it's how patients get medications in non-standard doses, alternative delivery methods, or formulations without certain allergens.
What changed the game for GLP-1 access is this: when Wegovy and Ozempic were placed on the FDA's official drug shortage list, compounding pharmacies became legally permitted to prepare patient-specific versions of the same active molecules — semaglutide and tirzepatide — at a fraction of the brand-name cost. A prescription is still required, but a growing number of telehealth providers make that accessible.
The Key Distinctions
Same molecule, different source. Compounded semaglutide and tirzepatide contain the same active ingredient as Wegovy, Ozempic, Mounjaro, and Zepbound. The difference is they're prepared by a pharmacy rather than manufactured at scale by Novo Nordisk or Eli Lilly. Quality and sterility standards vary by facility — using a 503B outsourcing facility (versus a standard 503A compounding pharmacy) generally provides a higher level of oversight and quality control.
Regulations are changing — tirzepatide status update. The FDA's drug shortage status for semaglutide and tirzepatide has shifted over time. The FDA lifted the tirzepatide shortage designation in October 2025. This means compounding pharmacies can no longer legally prepare tirzepatide under the broad shortage exemption that existed through 2024–2025. Some pharmacies continue operating under patient-specific medical necessity claims, but legal standing varies by state and enforcement is inconsistent. The FDA has issued warning letters and is actively monitoring. Semaglutide's shortage status has fluctuated separately — verify separately with your provider. Before sourcing any compounded tirzepatide, have an explicit conversation with your prescribing provider about current legal status and your options.
A prescription is required. Compounded GLP-1s are not available without a licensed provider's prescription. Telehealth platforms have made this more accessible, but be diligent about who you're working with. Look for providers who do a real medical intake, not just a quick checkbox approval.
Compounding pharmacies can legally prepare semaglutide and tirzepatide at lower cost — with a prescription. Same active molecule, regulated by the state and FDA. Legitimate path. Not the gray market.
The key watchouts: regulations around compounded GLP-1s are evolving, quality varies by facility, and a real prescription from a real provider is non-negotiable. Do your homework on the pharmacy — 503B outsourcing facilities offer the most rigorous standards.
When we came back from Portugal and started running low on our supply, compounding pharmacies were one of the first legitimate paths we explored. The cost difference from brand-name is significant — we're talking hundreds of dollars a month versus over a thousand. For people who've been priced out entirely, this is a real option worth understanding.
I'll be honest: the regulatory landscape was confusing to navigate. The rules changed multiple times in a short period. What I'd say is — start with a provider you trust, ask specifically about 503B facilities, and stay current on where the FDA stands. It's worth the extra diligence.